Last reviewed · How we verify

NCT06045143

Right Ventricular Septal Versus Apical Pacing: Echocardiographic Study

Status unknown Last updated 25 September 2023
What this trial tests

trial testing Patients undergoing DDD pacemaker implantation in Pacemaker DDD in 54 participants. Status unknown.

Timeline
1 October 2023
Primary endpoint
1 October 2024
1 December 2024

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment54
Start date1 October 2023
Primary completion1 October 2024
Estimated completion1 December 2024

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 90, any sex, with Pacemaker DDD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare the effect right ventricular apical versus septal pacing on left ventricular function by deformation imaging using 2D speckle tracking echocardiography.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pacemaker DDD

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06045143.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing